Application of an NMR/Crystallography Fragment Screening Platform for the Assessment and Rapid Discovery of New HIV‐CA Binding Fragments
Open Access
- 6 May 2024
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 19 (13) , e202400025
Abstract
Identification and assessment of novel targets is essential to combat drug resistance in the treatment of HIV/AIDS. HIV Capsid (HIV‐CA), the protein playing a major role in both the early and late stages of the viral life cycle, has emerged as an important target. We have applied an NMR fragment screening platform and identified molecules that bind to the N‐terminal domain (NTD) of HIV‐CA at a site close to the interface with the C‐terminal domain (CTD). Using X‐ray crystallography, we have been able to obtain crystal structures to identify the binding mode of these compounds. This allowed for rapid progression of the initial, weak binding, fragment starting points to compounds 37 and 38, which have 19F‐pKi values of 5.3 and 5.4 respectively.Keywords
All Related Versions
Funding Information
- Medical Research Council (MC_PC_18044)
This publication has 45 references indexed in Scilit:
- Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitorsBioorganic & Medicinal Chemistry, 2021
- Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound libraryEuropean Journal of Medicinal Chemistry, 2018
- Synthesis and evaluation of 2-pyridinylpyrimidines as inhibitors of HIV-1 structural protein assemblyBioorganic & Medicinal Chemistry Letters, 2016
- Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: Structure–activity relationships (SAR) of the C3-phenyl moietyBioorganic & Medicinal Chemistry Letters, 2013
- Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 1: Addressing configurational instability through scaffold modificationBioorganic & Medicinal Chemistry Letters, 2013
- Inhibition of HIV-1 capsid assembly: Optimization of the antiviral potency by site selective modifications at N1, C2 and C16 of a 5-(5-furan-2-yl-pyrazol-1-yl)-1H-benzimidazole scaffoldBioorganic & Medicinal Chemistry Letters, 2012
- Discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assemblyBioorganic & Medicinal Chemistry Letters, 2011
- Virtual screening based identification of novel small-molecule inhibitors targeted to the HIV-1 capsidBioorganic & Medicinal Chemistry, 2011
- X-Ray Structures of the Hexameric Building Block of the HIV CapsidCell, 2009
- Characterization of Ligand Binding by Saturation Transfer Difference NMR SpectroscopyAngewandte Chemie International Edition, 1999